ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,873, issued on March 4, was assigned to CureVac SE (Tubingen, Germany).
"Respiratory syncytial virus (RSV) vaccine" was invented by Thomas Kramps (Tubingen, Germany), Margit Schnee (Tubingen, Germany), Daniel Voss (Tubingen, Germany) and Benjamin Petsch (Tubingen, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an mRNA sequence, comprising a coding region, encoding at least one antigenic peptide or protein of RSV infections Respiratory syncytial virus (RSV) or a fragment, variant or derivative thereof. Additionally the present invention relates to a composition comprising a plurality of mRNA sequences comprisi...